Jyothy Labs schedules one-on-one investor meet with Asit C. Mehta on Sep 8

0 min read | Published on 04 Sept 2026, 05:00 PM |Updated on 04 Sept 2026, 10:28 PM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

Key Highlights

Jyothy Labs schedules one-on-one meet on September 8, 2026
Investor is Asit C. Mehta Investment Intermediates Ltd
Meeting conducted under SEBI LODR Regulation 30
No UPSI proposed to be shared during session

*this image is generated using AI for illustrative purposes only.

Jyothy Laboratories has scheduled a one-on-one meeting with Asit C. Mehta Investment Intermediates Ltd on September 8, 2026.

Meeting details

The engagement is part of the company’s standard investor relations activity under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Representatives of Jyothy Labs Limited will attend the session.

Parameter	Details
Event	One-on-one meeting with analysts and investors
Date	September 8, 2026
Investor	Asit C. Mehta Investment Intermediates Ltd
Company	Jyothy Laboratories

The company stated that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during the meeting. The schedule may change due to exigencies on the part of the investor or the company. The latest Investor Presentation is available on the company website.

Historical Stock Returns for Jyothy Laboratories

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.76%	-2.79%	-10.83%	-11.58%	-40.31%	0.0%

What specific strategic initiatives or financial performance metrics is Asit C. Mehta likely to prioritize in their discussion with Jyothy Laboratories?

How might the insights gained from this meeting influence Jyothy Laboratories' stock valuation or analyst ratings in the short term?

Are there any upcoming product launches or market expansion plans that Jyothy Laboratories might highlight to investors following this engagement?

Jyothy Laboratories

View Company Insights

View All News

Nalanda India Equity Fund raises Jyothy Labs stake to 7.61%

0 min read | Published on 04 Sept 2026, 11:51 AM |Updated on 04 Sept 2026, 11:51 AM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

Key Highlights

Nalanda India Equity Fund acquired 3,102,384 Jyothy Labs shares on Sept 2, 2026
Stake rose from 6.76% to 7.61% with total holding at 27,940,830 shares
Transaction settled on Sept 3, 2026 via exchange mechanism
No warrants or convertible securities involved in the acquisition

*this image is generated using AI for illustrative purposes only.

Nalanda India Equity Fund Limited increased its stake in Jyothy Laboratories to 7.61% following a recent share acquisition.

The Mauritius-based fund purchased 3,102,384 shares carrying voting rights on the exchange, raising its total holding from 24,838,446 shares (6.76%) to 27,940,830 shares.

Transaction Details

The acquisition was executed through open market transactions on September 2, 2026, with settlement completed on September 3, 2026. The transaction did not involve any warrants, convertible securities, or encumbered shares.

Metric	Before Acquisition	Acquired	After Acquisition
Shares (voting rights)	24,838,446	3,102,384	27,940,830
Stake percentage	6.76%	0.85%	7.61%

Jyothy Laboratories Limited has an equity share capital of 367,214,511 shares. The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Arshad Goodur, Director at Nalanda India Equity Fund Limited, signed the disclosure form dated September 3, 2026.

Historical Stock Returns for Jyothy Laboratories